6505--F-18 PSMA Pylarify
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- 36C24625R0016
- Agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36C24625D0023-36C24625D0023
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 has issued a Limited / Sole Source Justification Notice for procuring F-18 Pylarify (piflufolastat) radiopharmaceutical for the Durham VA Medical Center. The contract is an Indefinite Delivery Indefinite Quantity (IDIQ) award to Progenics Pharmaceuticals Inc., the sole manufacturer of this specific diagnostic agent for prostate cancer PET imaging. The contract has a one-year base period from January 1, 2025 through December 31, 2025, with three additional one-year option periods, and was awarded on December 30, 2024, for $5,990,475.20. The justification for sole source procurement is based on Progenics being the exclusive manufacturer of F-18 Pylarify, with alternative PSMA imaging agents deemed unsuitable due to different performance characteristics or shorter half-life limitations. Progenics Pharmaceuticals Inc. is classified as a small business under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) with fewer than 1,300 employees, and a notice of intent was posted on SAM.gov from December 6-10, 2024, with no alternative source responses received.
Notice text
This action is a new requirement to procure F-18 Pylarify (piflufolastat or 18F-DCFPyl) radiopharmaceutical for deliveries to be made to the Durham VA Medical Center located at 508 Fulton Street, Durham, North Carolina 27705. An open market Indefinite Delivery Indefinite Quantity contract (IDIQ) will be awarded with a one-year base period and three (3) one-year option periods. The period of performance will be from January 1, 2025 through December 31, 2025 for the base period of the contract. The total estimated value of this action, including the base period and all option periods, is $[REDACTED]. The NAICS code for this action is 325412, Pharmaceutical Preparation Manufacturing with a size standard of 1300 employees. The manufacturer, PROGENICS PHARMACEUTICALS INC (UEI: YLYKVRPCTCR3), is the only source for F-18 Pylarify. PROGENICS PHARMACEUTICALS INC (UEI: YLYKVRPCTCR3) is a small business under NAICS 325412 with less than 1300 employees. Awarded contract 36C24625D0023 to PROGENICS PHARMACEUTICALS INC for 5990475.20000000 on 2024-12-30.
Files
| File | Type | Posted |
|---|---|---|
| 36C24625D0023_2.docx | DOCX document | |
| REDACTED FAR 13.5 Sole Source Justification - SAT-7.5M F18 Pylarify.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Limited / Sole Source Justification | |
| 6505--F-18 PSMA Pylarify | Award Notice | |
| 6505--F-18 PSMA Pylarify | Special Notice |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity